We now know that cancer is many different diseases, with great variation even within a single histological subtype. With the current emphasis on developing personalized approaches to cancer treatment, it is astonishing that we have not yet systematically incorporated the biology of sex differences into our paradigms for laboratory and clinical...
Withania somnifera (Family: Solanaceae), commonly known as Ashwagandha or Indian ginseng is distributed widely in India, Nepal, China and Yemen. The roots of plant consist of active phytoconstituents mainly withanolides, alkaloids and sitoindosides and are conventionally used for the treatment of multiple brain disorders.
A new analysis of the SPARCL trial has shown that in patients with recent stroke or transient ischemic attack (TIA), the total number of vascular events prevented with atorvastatin was more than twice the number of first events prevented.
To examine the association between serum total homocysteine levels (tHcy) and dementia risk.
Multiple Sclerosis (MS) is a common disease in young adults but rare in children. More than a dozen treatments have been approved by the
Due to the state of emergency declared in our country, the scheduled medical consultations in our center located in the Vithas Jaime I Hospital were cancelled until further notice.
After a few weeks of uncertainty we are pleased to inform you that all our private patients will be able to attend their appointment at the usual time.
Since the Centers for Disease Control and Prevention (CDC) confirmed the first US case of novel coronavirus infection on January 20, much of the clinical focus has naturally centered on the virus' prodromal symptoms and severe respiratory effects.
Variations in the composition of the microbiota are associated with different multiple sclerosis (MS) phenotypes, according to a new study published in Annals of Clinical and Translational Neurology. the findings demonstrate the importance of patient stratification in studies of the microbiota in MS and also identify potential therapeutic targets...
A second phase 3 study of the investigational drug MD1003 (MedDay Pharmaceuticals), a highly concentrated pharmaceutical-grade biotin being studied for multiple sclerosis (MS), did not meet its primary and secondary endpoints, the company announced.
Individuals with radiologically isolated syndrome (RIS) have incidental magnetic resonance imaging (MRI) abnormalities suggestive of multiple sclerosis (MS).
